Logotipo do repositório
 

Publicação:
Efeito da lavagem peritoneal com bupivacaína na sobrevida de ratos com peritonite fecal

dc.contributor.authorBrocco, Marcos Célio
dc.contributor.authorPaulo, Danilo Nagib Salomão
dc.contributor.authorBaptista, João Florêncio de Abreu
dc.contributor.authorCarraretto, Antônio Roberto [UNESP]
dc.contributor.authorFerrari, Thiago Antunes
dc.contributor.authorDe Azevedo, Thiago Caetano V.
dc.contributor.authorDa Silva, Alcino Lázaro
dc.contributor.institutionUniversidade Federal do Espírito Santo (UFES)
dc.contributor.institutionUniversidade Federal de Minas Gerais (UFMG)
dc.contributor.institutionEMESCAM
dc.contributor.institutionHospital Universitário Cassiano Antônio de Moraes
dc.contributor.institutionUniversidade Estadual Paulista (Unesp)
dc.contributor.institutionCET Integrado HUCAM-HAFPES
dc.date.accessioned2014-05-27T11:23:39Z
dc.date.available2014-05-27T11:23:39Z
dc.date.issued2008-09-01
dc.description.abstractBACKGROUND AND OBJECTIVES: Based on the knowledge of the anti-inflammatory and anti-bacterial actions of local anesthetics (LA), the objective of this study was to determine the effects of peritoneal lavage with bupivacaine on survival of mice with fecal peritonitis. METHODS: Forty-eight Wistar mice, weighing between 300 and 330 g (311.45 ± 9.67 g), undergoing laparotomy 6 hours after induction of peritonitis were randomly divided in 4 groups: 1 - Control, without treatment (n = 12); 2 - Drying of the abdominal cavity (n = 12); 3 - Lavage with 3 mL NS and posterior drying of the abdominal cavity (n = 12); and 4 - Lavage with 8 mg.kg -1 (± 0.5 mL) of 0.5% bupivacaine added to 2.5 mL of NS followed by drying out of the abdominal cavity (n = 12). Animals that died underwent necropsy and the time of death was recorded. Surviving animals were killed on the 11 th postoperative day and underwent necropsy. RESULTS: Group 1 presented a 100% mortality rate in 52 hours, 100% mortality rate in Group 2 in 126 hours, and Group 3 presented a 50% mortality rate in 50 hours. Animals in Group 4 survived. Survival on the 11 th day was greater in groups 3 and 4 than in Groups 1 and 2 (p < 0.001) and greater in Group 4 than in Group 3 (p < 0.01). CONCLUSIONS: Peritoneal lavage with a solution of bupivacaine diluted in NS was effective in preventing death for 11 days in 100% of animals with fecal peritonitis. © Sociedade Brasileira de Anestesiologia, 2008.en
dc.description.affiliationAnestesiologia UFES
dc.description.affiliationUniversidade Federal de Minas Gerais (UFMG)
dc.description.affiliationCirurgia EMESCAM
dc.description.affiliationHospital Universitário Cassiano Antônio de Moraes, Vitória, ES
dc.description.affiliationFaculdade de Medicina de Botucatu UNESP
dc.description.affiliationCET Integrado HUCAM-HAFPES
dc.description.affiliationCurso de Medicina EMESCAM
dc.description.affiliationCirurgia Faculdade de Medicina UFMG
dc.description.affiliation, Rua Pedro Luis Zanandréa, 55 - Mata da Praia, 29065-610 Vitória, ES
dc.description.affiliationUnespFaculdade de Medicina de Botucatu UNESP
dc.format.extent470-479
dc.identifierhttp://dx.doi.org/10.1590/S0034-70942008000500005
dc.identifier.citationRevista Brasileira de Anestesiologia, v. 58, n. 5, p. 470-479, 2008.
dc.identifier.doi10.1590/S0034-70942008000500005
dc.identifier.file2-s2.0-52249109828.pdf
dc.identifier.issn0034-7094
dc.identifier.issn1806-907X
dc.identifier.scieloS0034-70942008000500005
dc.identifier.scopus2-s2.0-52249109828
dc.identifier.urihttp://hdl.handle.net/11449/70545
dc.language.isopor
dc.relation.ispartofRevista Brasileira de Anestesiologia
dc.relation.ispartofjcr0.850
dc.relation.ispartofsjr0,320
dc.rights.accessRightsAcesso abertopt
dc.sourceScopus
dc.subjectAnesthetic, local: Bupivacaine
dc.subjectAnimals: Mice
dc.subjectComplications, infection: Peritonitis
dc.subjectamikacin
dc.subjectaminoglycoside antibiotic agent
dc.subjectamoxicillin plus clavulanic acid
dc.subjectampicillin
dc.subjectantibiotic agent
dc.subjectbupivacaine
dc.subjectcefazolin
dc.subjectceftriaxone
dc.subjectcephalosporin derivative
dc.subjectciprofloxacin
dc.subjectclindamycin
dc.subjectcotrimoxazole
dc.subjecterythromycin
dc.subjectgatifloxacin
dc.subjectgentamicin
dc.subjectketamine
dc.subjectlevofloxacin
dc.subjectlidocaine
dc.subjectlinezolid
dc.subjectlocal anesthetic agent
dc.subjectnitrofurantoin
dc.subjectnorfloxacin
dc.subjectoxacillin
dc.subjectpenicillin derivative
dc.subjectquinoline derived antiinfective agent
dc.subjectrifampicin
dc.subjectropivacaine
dc.subjectsultamicillin
dc.subjectunindexed drug
dc.subjectvancomycin
dc.subjectanimal experiment
dc.subjectanimal model
dc.subjectantibacterial activity
dc.subjectantibiotic sensitivity
dc.subjectantiinflammatory activity
dc.subjectcontrolled study
dc.subjectdrug effect
dc.subjectfeces
dc.subjectGram negative bacterium
dc.subjectGram positive bacterium
dc.subjectimmune response
dc.subjectlaparotomy
dc.subjectmortality
dc.subjectmouse
dc.subjectnonhuman
dc.subjectperitoneal cavity
dc.subjectperitoneum lavage
dc.subjectperitonitis
dc.subjectsepsis
dc.subjectsurvival rate
dc.titleEfeito da lavagem peritoneal com bupivacaína na sobrevida de ratos com peritonite fecalpt
dc.title.alternativeEffects of peritoneal lavage with bupivacaine on survival of mice with fecal peritonitisen
dc.typeArtigopt
dcterms.licensehttp://www.scielo.br/revistas/rba/paboutj.htm
dspace.entity.typePublication
unesp.campusUniversidade Estadual Paulista (UNESP), Faculdade de Medicina, Botucatupt

Arquivos

Pacote Original

Agora exibindo 1 - 1 de 1
Carregando...
Imagem de Miniatura
Nome:
2-s2.0-52249109828.pdf
Tamanho:
62.95 KB
Formato:
Adobe Portable Document Format